ETFsMSCI Japan ESG Broad CTB Select Index
Amundi

Amundi MSCI Japan ESG Broad Transition UCITS ETF Hedged EUR Acc

AHYZ XETRAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
108.66EUR
-2.13% · -€2.36
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
AHYZBase
Fund charges
0.20%Total expense ratio (TER)
Fund size
€1.3bnall share classes
Return 1Y
+19.1%
Sharpe 3Y
0.93
Volatility 1Y
18.8%annualised
Holdings
127Fund holdings

Performance

Compare
  • AHYZ+19.1%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
AHYZ-7.1%-4.3%+4.2%+14.8%+19.1%+74.0%-
MSCI World-2.8%-0.6%+7.8%+14.0%+14.1%+65.6%+64.8%
Gap to MSCI World-4.3%-3.7%-3.6%+0.8%+5.0%+8.4%-

Risk and return

Sharpe ratio · 3Y
0.93
Below MSCI World · 1.24
Return p.a.
+20.8%
Volatility
19.4%
Max loss
-20.4%Aug 2024

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
AHYZ
0.93
CAC 40
0.37
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
30.8%
Holdings
127
As of
Fund holdings
  1. 1MITSUBISHI UFJ FINANCIAL GROUPJP39029000044.59%
  2. 2TOYOTA MOTOR CORPJP36334000013.70%
  3. 3SONY GROUP CORP (JT)JP34350000093.42%
  4. 4ADVANTEST CORP Y50JP31224000093.39%
  5. 5SUMITOMO MITSUI FINANCIAL GROUPJP38903500063.15%
  6. 6TOKYO ELECTRON JPY50JP35714000052.78%
  7. 7RECRUIT HOLDINGS CO LTDJP39703000042.76%
  8. 8MIZUHO FINANCIAL GROUP INCJP38857800012.51%
  9. 9TAKEDA PHARMACEUTICALJP34630000042.27%
  10. 10KEYENCE CORP JPY50JP32362000062.25%

Countries

Classified 99.0%
Largest
99.0%Japan
Top 3
99.0%
Effective number
1.01 / HHI

Market cap

Weight vs holdings

30.8%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-127

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.